EU To Sue AstraZeneca Over Vaccine Delivery: Can Either Side Win?
First Ruling Could Come This Week
The legal challenge is risky for the European Commission, with AZ’s contract only binding it to make ‘best reasonable efforts’ to deliver vaccines to schedule.
You may also be interested in...
AstraZeneca and Sanofi have leapt forward in their plans to shake up the RSV market with earlier than expected positive data for their passive immunization product nirsevimab. Rival maternal vaccines in development will cast a shadow, however.
Once expected to play a key role in beating COVID-19, Sanofi and GSK now see their vaccine as most likely to be used as a booster.
Promising early-stage data from two companies looking to break into crowded hemato-oncology markets.